KYOWA PHARMACEUTICALS

Lupin looks to sell Japanese arm Kyowa for $600 million

In August, Lupin sold its injectables business to neo ALA Co, a wholly owned subsidiary of Abu Dhabi based Neopharma group, for an undisclosed sum to help streamline Japanese operations and increase focus on branded generics.